All news

Adial Pharmaceuticals rebrands as Azora Therapeutics, ticker AZR

Alpha Vantage · StreetInsider · · AI-summarised by FinFlash

Adial Pharmaceuticals has rebranded as Azora Therapeutics, Inc., with its common stock trading under the ticker "AZR" on the Nasdaq Capital Market starting October 29, 2026. The change follows stockholder approval to convert Series A preferred stock and exercise prefunded warrants tied to its June 2026 Azora acquisition.

Read original source

ADIL company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.